Activists and Leaders at Global HIV Meeting Decry Price of Prevention Drug

AIDS activists slam ‘pharma greed’ over breakthrough drug

Despite participating in clinical trials, middle-income countries have been excluded from access to a generic version of the prevention drug.

AIDS activists slam 'pharma greed' over breakthrough drug

Despite participating in clinical trials, middle-income countries like Brazil, Argentina and Mexico have been excluded from access to a generic version of the drug, which researchers say can be produced for $40 a year. Protesters burst onto the stage at the opening of the 26th International AIDS Conference in Rio de Janeiro bearing signs reading: "Pharma greed is killing us," and "You use our bodies then deny us access." "How can Latin America s…

Activists and leaders at global HIV meeting decry price of prevention drug

Gilead is criticized for lack of affordable access to lenacapavir in Latin America

Brazil Pushes For Inclusion In Pharma Deals For Long-Acting HIV Prevention Drugs

RIO DE JANEIRO – News that an antiretroviral drug injected twice a year had prevented almost all HIV infection in trials electrified the HIV sector two years ago – but access to Gilead’s lenacapavir has been slow, particularly for countries in Latin America. Brazil, which faces significant HIV transmission in certain groups, has been routinely […]